DVAX - Dynavax Technologies Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
29,967
8,198
327
11,043
Cost of Revenue
18,608
21,796
-
-
Gross Profit
11,359
-13,598
-
-
Operating Expenses
Research Development
72,954
74,951
64,988
84,493
Selling General and Administrative
71,106
64,770
27,367
37,257
Total Operating Expenses
144,060
139,721
93,549
121,750
Operating Income or Loss
-132,701
-153,319
-93,222
-110,707
Interest Expense
14,862
9,338
0
0
Total Other Income/Expenses Net
-11,742
-70
-3,269
-2,492
Income Before Tax
-155,813
-158,899
-95,154
-112,444
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-155,813
-158,899
-95,154
-112,444
Net Income
-155,813
-158,899
-95,154
-112,444
Net Income available to common shareholders
-159,080
-158,899
-95,154
-112,444
Reported EPS
Basic
-
-2.55
-1.81
-2.92
Diluted
-
-2.55
-1.81
-2.92
Weighted average shares outstanding
Basic
-
62,362
52,613
38,506
Diluted
-
62,362
52,613
38,506
EBITDA
-
-149,561
-92,028
-110,707